ZUG, Switzerland and STOCKHOLM, March 16, 2016 /PRNewswire/ -- Pushing its reputation for taking novel approaches, Karolinska Institutet is bringing together the best and the brightest from Sweden's early academic innovator ecosystem to present their technologies and test their skills in convincing business development executives to support their projects.
"Developing a pitch is all about competence, convincing people that you can execute on your plan," said Lily Cortese, who directs Business Operations and Project Management at the Johnson & Johnson Innovation Centre, London, and is sponsoring the session.
"Investors are going to think about the business aspects of that asset and the scientists are going to be looking at the scientific aspects of the asset. Ultimately we are all investing in the people, in a belief that this team will be able to do what they say they can do," said Cortese.
The session aims to help these entrepreneurs up their game, to hone their skills for pitching their project and win the confidence of stakeholders, she said.
According to Mark Farmery, Senior Manager for Business Development with KI Innovations, the start-up companies eligible to pitch have been formed in the last three to five years, are developing a new therapeutic product or medical technology platform that is validated in the lab and have aggregate funding of USD 10 million or less.
"It's going to be a great event, and a fun way for us to show off our collaboration with Karolinska Institutet," said Cortese. "There will be judges, and I'll be co-hosting with Mark. BIO-Europe Spring is always keeping things new and fresh, and we're really pleased to be part of that effort as well."
After prizes are awarded, the competition will be followed by networking opportunities with the entrepreneurs during an evening dinner reception hosted by Hagastaden Property Developers with Karolinska Institutet and Stockholm Science City at the prestigious Aula Medica where Nobel lectures in Physiology or Medicine are given, followed by an After Hours Making the Connection Networking Reception hosted by J&J Innovations.
Registration information for BIO-Europe Spring is available online.
Additional links and information:
Follow BIO-Europe Spring 2016 on Twitter: @EBDGroup (hashtag: #BES16).
Online Press Kit service for BIO-Europe Spring 2016 is available from Virtual Press Office/PR Newswire to enhance your public relations efforts.
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group's conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe® and BIO-Europe Spring®, Europe's largest life science partnering conferences, supported by the Biotechnology Innovation Organization (BIO)
- BioPharm America™, the fastest growing partnering event in North America
- Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
- ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® Group
- Biolatam®, facilitating partnering among global life sciences executives in Latin America's vibrant life science hubs
EBD Group's sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.
SOURCE EBD Group